Bristol-Myers Squibb Co. (NYSE:BMY)

AbbVie, Celgene and 2 More Major Biotechs Reporting Earnings Thursday

Earnings season is now in full swing, and we have put together a preview of some of the world’s largest biotechnology and pharmaceutical companies reporting their earnings on Thursday. With ...
Read Full Story »

Short Sellers Can’t Make Up Their Minds on Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Top Dividend Pharmaceutical Stocks Safe Bet for Rest of 2017

One thing that crept on the radar screen last week is that after eight years of a bull market, five of which are of the secular variety, after the S&P 500 ...
Read Full Story »

Short Sellers Run for Cover From Major Pharma Stocks

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Major Pharma Short Sellers Couldn’t Make Up Their Minds Before Failed Trump Health Care Vote

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »

Monday’s Top Biopharma Movers

A few biopharma stocks made massive runs on Monday morning. The broad markets are holding near their all-time highs, and part of the run up to this level is attributed ...
Read Full Story »

Short Sellers Back Off Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
Aluminum rolls

Insider Buying Steady as Market Again Hits All-Time Highs: Arconic, Murphy’s USA, Bristol-Myers, Avon and More

In what is becoming something of a Groundhog Day–type scenario, the market continued its climb to record highs across the board last week. While things slowed near the end of the ...
Read Full Story »
Prescription drugs

Why Short Sellers Are Making a Massive Bet in Major Pharma

Pharmaceutical companies usually are involved in a lengthy process of getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
reprimand

3 Big Companies Buckling to Activist Investors

It seems as though activist investors still have a major role in the ups and downs of the stock market. Some activist efforts help companies through time, while others look ...
Read Full Story »
Apple logo

Apple Named World’s Most Innovative Company

For the 11th consecutive year, Apple Inc. (NASDAQ: AAPL) has been named the world's most innovative company by The Boston Consulting Group (BCG). In nine of those years, Google/Alphabet Inc. (NASDAQ: ...
Read Full Story »
Pair of dice

Are Short Sellers Doubting Trump by Hiking Bets in Major Pharma?

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
Stock Price

Bristol-Myers, Mattel Plunge into Thursday’s 52-Week Low Club

January 26, 2017: Here are four stocks trading with relatively heavy volume among 31 equities making new 52-week lows in Thursday's session. On the NYSE, decliners led advancers by about 8 ...
Read Full Story »
Prescription drugs

Short Sellers Run for Cover From Major Pharma

Pharmaceutical companies usually are involved in a lengthy process in getting their drug candidates to market through clinical trials. There is a fair amount of risk involved, should a study ...
Read Full Story »
Stock Price

Bristol-Myers, DryShips Drop into Wednesday’s 52-Week Low Club

January 25, 2017: Here are four stocks trading with relatively heavy volume among 22 equities making new 52-week lows in Wednesday's session. On the NYSE, advancers led decliners by nearly ...
Read Full Story »